Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...

After four days in Berlin attending the massive annual meeting of the International Parkinson’s and Movement Disorders Society, 23andMe Parkinson’s Community manager, Paul Cannon, PhD, came back hopeful for the...

The panel discussing Parkinson’s Progression Marker Initiative at the MJFF’s Parkinson’s Disease Therapeutics Conference in New York. From implanting cells into the brain to prevent the loss of dopamine producing...

We’re re-posting an interview that the Michael J. Fox Foundation did with our very own Paul Cannon, PhD, 23andMe’s Parkinson’s Research Community manager. April is Parkinson’s Awareness Month and this...